October 2-4, 2019 | Sonesta Rittenhouse Square | Philadelphia, PA
www.cbinet.com/coupon
Exclusive Offer – Register by 8/23/2019 and
save $500* (mention promo code COUPDC)
save $500* (mention promo code COUPDC)
These continue to be turbulent times for life sciences manufacturers, as the drug pricing debate shows no signs of wavering, state legislation to ban copay accumulator programs intensifies, and rebate reform gets replaced by Trump’s push for ‘most favored nation” drug pricing policy. Staying on the pulse of the patient affordability landscape and overcoming patient access barriers by leveraging strategic copay programs is more paramount than ever.
CBI's flagship Coupon and Copay Conference, taking place October 2-4 in Philadelphia, is an important event devoted exclusively to designing (and re-designing) copay programs aimed at driving patient access and affordability to offset high-cost therapies and deductibles.
By popular demand, the 2019 agenda includes an all-new programming feature with one day of content devoted to the pressing topic of copay accumulators. Don’t miss three full days of jam-packed content on coupons, copays and accumulators covering:
- State and federal progress regulating copay accumulator programs
- Alternative copay strategies to respond to the rise of copay accumulator and maximizer programs
- Shifts in benefit plan design today and over the next 2-5 years
- Drug pricing legislation and potential impact on patient access
- Innovative copay program designs
- Impact of copay assistance programs on overall healthcare costs
- Potential effect of the price transparency debate and consumerism on patient adherence rates
- Performance metrics to justify the cost of copay programs
- And so much more!
*Discount offer valid through 8/23/2019; applies to standard rates only and may not be combined with other offers, categories, promotions or applied to an existing registration.
The content of Sponsored Posts does not necessarily reflect the views of Pembroke Consulting, Inc., Drug Channels, or any of its employees.
No comments:
Post a Comment